Immunohistochemistry showed that DCA treatment increased the percentage of positive cells of ADAM‐17 in intestinal tumour in Apcmin/+ mice (75.00 ± 2.35 vs 36.33 ± 1.94, P < .001, Figure 5A). Here, ADAM17 is linked to intestinal neoplasm.